Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Lianjun Xing"'
Autor:
Junqiu Li, Jielu Pan, Dinghong Xiao, Nan Shen, Ruiqing Wang, Hongyv Miao, Peimin Pu, Haiyan Zhang, Xiao Yv, Lianjun Xing
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background Previous literature has explored the relationship between chronic atrophic gastritis (CAG) and isolated cancers within the upper gastrointestinal cancers; However, an integrative synthesis across the totality of upper gastrointest
Externí odkaz:
https://doaj.org/article/fcbb7cdf1506412db34635f0b086dfa3
Autor:
Xiao Yu, Haiyan Zhang, Jielu Pan, Lu Zou, Ling Tang, Hongyu Miao, Peiyong Zheng, Lianjun Xing
Publikováno v:
Pharmaceutical Biology, Vol 59, Iss 1, Pp 1359-1368 (2021)
Context Jiang Zhi Granule (JZG) is known to improve hepatic function, reduce liver fat deposition and inflammation in non-alcoholic fatty liver disease (NAFLD). Objective To determine the protective mechanism of JZG on immunological barrier of intest
Externí odkaz:
https://doaj.org/article/19deb14cc880415b97140afd1a9c118c
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2023:1-14
Background. Qinggan Huoxue recipe (QGHXR), a traditional Chinese medicinal formula, has a protective effect against liver fibrosis. However, the underlying mechanisms remain unclear. Objective. This study investigated the antifibrotic role of QGHXR a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66771dc19cbc7bb1b41cee27c94c4cb
https://doi.org/10.1155/2023/5642713
https://doi.org/10.1155/2023/5642713
Publikováno v:
Annals of Palliative Medicine. 10:7697-7705
BACKGROUND This meta-analysis aimed to evaluate the effectiveness of fibrates in the treatment of pruritus in patients with primary biliary cholangitis (PBC), so as to guide the clinical treatment of such cases. METHODS Searches of the PubMed, Google
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5d2cc9d1009924080f3cedb72f3d39
https://doi.org/10.21037/apm-21-1304
https://doi.org/10.21037/apm-21-1304
Autor:
Nan Shen, Ling Tang, Yufan Qian, Jielu Pan, Jiashu Pan, Hongyu Miao, Haiyan Zhang, Hong Fang, Xiao Yu, Lianjun Xing
In lean individuals, NAFLD is not a benign disease,and these patients have longterm morbidity and mortality similar to those of their nonlean counterparts.It is urgent to find biomarkers for noninvasive and early detection. miRNAs are useful biomarke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa9f2b98b361bed02d20dbfb25c84172
https://doi.org/10.21203/rs.3.rs-1782547/v1
https://doi.org/10.21203/rs.3.rs-1782547/v1
Publikováno v:
Materials Express. 11:601-617
Asthma is considered as a difficult chronic disease with prolonged inflammation, reversible obstruction and remodeling in the airway. The present work aimed to examine the therapeutic efficacy of Bergenin-loaded Cationic Liposome (B-CLs) in asthma. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a48ff7ca59e72dbe42f62b8cef8bb0c7
https://doi.org/10.1166/mex.2021.1949
https://doi.org/10.1166/mex.2021.1949
Autor:
Hongrun Wang, Shengjie Fan, Haiyan Zhang, Gen Chen, Lianjun Xing, Cheng Huang, Yahui Wang, Yuanyuan Zhao, Lingling Luo, Peiyong Zheng
Publikováno v:
Chemical Research in Toxicology. 34:833-838
Nonalcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation in the liver and associates with obesity, hyperlipidemia, and insulin resistance. NAFLD could lead to nonalcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::902bef3a7581a2f54848cc552a50af09
https://doi.org/10.1021/acs.chemrestox.0c00445
https://doi.org/10.1021/acs.chemrestox.0c00445
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 151
Nonalcoholic fatty liver disease (NAFLD) is a general term for a series of liver diseases including simple steatosis, non-alcoholic steatohepatitis, liver fibrosis, which is closely related to metabolic syndrome. The pathogenesis of NAFLD is relative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::737501d6d0c588280b0763a2f37a504d
https://pubmed.ncbi.nlm.nih.gov/35598367
https://pubmed.ncbi.nlm.nih.gov/35598367
Publikováno v:
Journal of biomedical nanotechnology. 17(4)
The mortality rate of ethanol induced liver disease has substantially raised to alert level with an increasing use of alcohol, but development of definite hepatoprotective drug is still challenging. The efficacy of Saikosaponin D, one of the natural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6928f1fdd6160b30f7bc2cdb462df9a
https://pubmed.ncbi.nlm.nih.gov/35057889
https://pubmed.ncbi.nlm.nih.gov/35057889
Autor:
Shengjie, Fan, Haiyan, Zhang, Yahui, Wang, Yuanyuan, Zhao, Lingling, Luo, Hongrun, Wang, Gen, Chen, Lianjun, Xing, Peiyong, Zheng, Cheng, Huang
Publikováno v:
Chemical research in toxicology. 34(3)
Nonalcoholic fatty liver disease (NAFLD) is characterized by lipid accumulation in the liver and associates with obesity, hyperlipidemia, and insulin resistance. NAFLD could lead to nonalcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e02ef494560a6a1dc2a7ae6e99932261
https://pubmed.ncbi.nlm.nih.gov/33647205
https://pubmed.ncbi.nlm.nih.gov/33647205